New adjuvant successful in extending immunity against HIV
ATLANTA – Researchers at the Yerkes National Primate Research Center and the Emory Vaccine Center (EVC) are first to show a new adjuvant, 3M-052, helps induce long-lasting immunity against HIV. The study results are published today in Science Immunology. In this pre-clinical study that included 90 rhesus monkeys, the researchers showed 3M-052, a new, synthetic…